Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.1
4.9
Journals
IJMS
Special Issues
The Brain as a Manager of Central and Peripheral Functions...
ijms-logo
Submit to Special Issue Submit Abstract to Special Issue Review for IJMS Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

The Brain as a Manager of Central and Peripheral Functions in Health and Disease

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 31 March 2025 | Viewed by 6281

Special Issue Editor

Prof. Dr. Michael Ugrumov

E-Mail Website
Guest Editor
1. Faculty of Psychology, National Research University “Higher School of Economy”, Moscow, Russia
2. Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia
Interests: developmental neurobiology; neuroendocrinology; neurodegenerative diseases; Parkinson’s disease; preclinical diagnosis; preventive neuroprotective therapy
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

I am pleased to invite you to contribute to this Special Issue of IJMS titled: “The Brain as a Manager of Central and Peripheral Functions in Health and Disease”. The brain plays a key role in the regulation of the development of the body and the brain (autoregulation) and central and peripheral functions in adulthood. These regulations are controlled by chemical signals—classical, neurotransmitters, neuropeptides, and amino acids. They are involved in synaptic or volume neurotransmission in the brain and neuroendocrine regulation when delivered to body fluids (CSF, blood). The role of brain-derived chemical signals during the so-called critical period of morphogenesis (the perinatal period) is fundamentally different compared to their role in adulthood. Indeed, in the perinatal period, before the closure of the blood–brain barrier, chemical signals exert an irreversible morphogenetic effect on differentiating target cells in the brain and peripheral organs. Impaired brain function during this period leads to the development of congenital neurological, mental, and neuroendocrine diseases. Data on the molecular mechanisms of brain diseases obtained using experimental models and pathological material are of particular importance since they can be applied to the development of new diagnostic and therapeutic technologies for patients.

Thus, this Special Issue of IJMS titled “The Brain as a Manager of Central and Peripheral Functions in Health and Disease” invites a wide range of studies on the molecular mechanisms of brain function in relation to ontogenesis, adulthood, health, and disease. Reviews, original papers, and new technological developments are welcome. Notably, according to Google Scholar Metrics 2024, IJMS ranks 22nd among the top 100 journals and 7th in the Life Sciences and Earth Sciences category.

Prof. Dr. Michael Ugrumov
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • brain
  • animals
  • humans
  • cells
  • neural regulation
  • neuroendocrine regulation
  • synaptic neurotransmission
  • volume neurotransmission
  • ontogenesis
  • blood–brain barrier
  • brain diseases
  • neurological diseases
  • mental diseases
  • congenital diseases
  • modeling of brain pathology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Related Special Issue

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

17 pages, 4701 KiB  
Article
Compensatory Processes in Striatal Neurons Expressing the Tyrosine Hydroxylase Gene in Transgenic Mice in a Model of Parkinson’s Disease
by Dmitry Troshev, Alyona Bannikova, Victor Blokhin, Ekaterina Pavlova, Anna Kolacheva and Michael Ugrumov
Int. J. Mol. Sci. 2023, 24(22), 16245; https://doi.org/10.3390/ijms242216245 - 13 Nov 2023
Cited by 5 | Viewed by 1954
Abstract
The mammalian striatum is known to contain non-dopaminergic neurons that express dopamine (DA)-synthesizing enzymes and produce DA, responsible for the regulation of motor function. This study assessed the expression of DA-synthesizing enzymes in striatal neurons and their role in DA synthesis in transgenic [...] Read more.
The mammalian striatum is known to contain non-dopaminergic neurons that express dopamine (DA)-synthesizing enzymes and produce DA, responsible for the regulation of motor function. This study assessed the expression of DA-synthesizing enzymes in striatal neurons and their role in DA synthesis in transgenic mice expressing the green fluorescent protein (GFP) gene under the tyrosine hydroxylase (TH) gene promoter in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson’s disease (PD). We showed that, in Parkinsonian animals, the number of neurons expressing the TH gene increased by 1.9 times compared with the control (0.9% NaCl), which indicates a compensatory response to the DAergic denervation of the striatum. This assumption is supported by a 2.5-fold increase in the expression of genes for TH and transcription factor Nurr1 and a 1.45-fold increase in the expression of the large amino acid transporter 1 gene. It is noteworthy that, in Parkinsonian mice, in contrast to the controls, DA-synthesizing enzymes were found not only in nerve fibers but also in neuronal cell bodies. Indeed, TH or TH and aromatic L-amino acid decarboxylase (AADC) were detected in GFP-positive neurons, and AADC was detected in GFP-negative neurons. These neurons were shown to synthesize DA, and this synthesis is compensatorily increased in Parkinsonian mice. The above data open the prospect of improving the treatment of PD by maintaining DA homeostasis in the striatum. Full article
(This article belongs to the Special Issue The Brain as a Manager of Central and Peripheral Functions in Health and Disease)
►▼ Show Figures

Figure 1

Review

Jump to: Research

36 pages, 1930 KiB  
Review
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
by Anamaria Jurcau, Felicia Liana Andronie-Cioara, Delia Carmen Nistor-Cseppento, Nicoleta Pascalau, Marius Rus, Elisabeta Vasca and Maria Carolina Jurcau
Int. J. Mol. Sci. 2023, 24(19), 14582; https://doi.org/10.3390/ijms241914582 - 26 Sep 2023
Cited by 21 | Viewed by 3537
Abstract
Parkinson’s disease is a neurodegenerative disease exhibiting the fastest growth in incidence in recent years. As with most neurodegenerative diseases, the pathophysiology is incompletely elucidated, but compelling evidence implicates inflammation, both in the central nervous system and in the periphery, in the initiation [...] Read more.
Parkinson’s disease is a neurodegenerative disease exhibiting the fastest growth in incidence in recent years. As with most neurodegenerative diseases, the pathophysiology is incompletely elucidated, but compelling evidence implicates inflammation, both in the central nervous system and in the periphery, in the initiation and progression of the disease, although it is not yet clear what triggers this inflammatory response and where it begins. Gut dysbiosis seems to be a likely candidate for the initiation of the systemic inflammation. The therapies in current use provide only symptomatic relief, but do not interfere with the disease progression. Nonetheless, animal models have shown promising results with therapies that target various vicious neuroinflammatory cascades. Translating these therapeutic strategies into clinical trials is still in its infancy, and a series of issues, such as the exact timing, identifying biomarkers able to identify Parkinson’s disease in early and pre-symptomatic stages, or the proper indications of genetic testing in the population at large, will need to be settled in future guidelines. Full article
(This article belongs to the Special Issue The Brain as a Manager of Central and Peripheral Functions in Health and Disease)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop